newsfilter
← Latest News
GlobeNewswire·

Ceapro Inc. Reports 2021 Second Quarter and Six-Month Financial Results and Operational Highlights

– Company continues to increase R&D activities to advance clinical and preclinical programs – – Second quarter sales of $4,409,000 compared to $4,666,000 for second quarter 2020 – – Cash generated from operations of $2,128,000 in Q2 2021